AKYA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $67,950.00

Akoya Biosciences Insider Trading History Chart

Akoya Biosciences Share Price & Price History

^$1.62

▲ +0.06 (3.85%)

As of 03/18/2025 05:00 PM ET

Days: 30 | 90 | 365

Akoya Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/11/2024	Brian Mckelligon	CEO	Sell	7,500	$2.08	$15,600.00	224,733
6/6/2024	Brian Mckelligon	CEO	Sell	7,500	$2.01	$15,075.00	224,733
3/20/2024	Brian Mckelligon	CEO	Sell	7,500	$4.97	$37,275.00	231,868
3/13/2024	Brian Mckelligon	CEO	Sell	7,500	$4.94	$37,050.00	224,368
12/19/2023	Brian Mckelligon	CEO	Sell	7,500	$4.48	$33,600.00	152,563
9/7/2023	Frederic Pla	COO	Buy	20,000	$4.60	$92,000.00	20,000
6/12/2023	John Frederick Ek	CFO	Buy	20,000	$5.00	$100,000.00	20,000
6/12/2023	Matthew Winkler	Director	Buy	203,388	$5.00	$1,016,940.00	984,513
6/6/2023	Brian Mckelligon	CEO	Sell	5,000	$5.71	$28,550.00	152,563
12/14/2022	Joseph Driscoll	CFO	Sell	24,613	$12.54	$308,647.02	12,500
12/13/2022	Garry Nolan	Director	Sell	100	$13.25	$1,325.00	555,084
12/2/2022	Garry Nolan	Director	Sell	1,100	$13.25	$14,575.00	591,978
11/16/2022	Garry Nolan	Director	Sell	300	$13.25	$3,975.00	598,078
11/14/2022	Garry Nolan	Director	Sell	600	$13.28	$7,968.00	598,378
11/10/2022	Garry Nolan	Director	Sell	3,810	$13.31	$50,711.10	618,978
9/14/2022	Garry Nolan	Director	Sell	8,305	$13.26	$110,124.30	622,788
9/12/2022	Garry Nolan	Director	Sell	1,800	$13.30	$23,940.00	631,093
9/9/2022	Garry Nolan	Director	Sell	22,191	$13.31	$295,362.21	632,893
9/7/2022	Brian Mckelligon	CEO	Sell	5,000	$12.83	$64,150.00	80,000

SEC Filings (Institutional Ownership Changes) for Akoya Biosciences (NASDAQ:AKYA)

79.42% of Akoya Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Akoya Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Deutsche Bank AG	54,788	$0.13M	0.0%	+404.1%	0.111%
2/17/2025	Bank of America Corp DE	29,092	$67K	0.0%	+39.6%	0.059%
2/14/2025	Jane Street Group LLC	17,802	$41K	0.0%	-41.5%	0.036%
2/14/2025	Schonfeld Strategic Advisors LLC	122,000	$0.28M	0.0%	-55.0%	0.246%
2/14/2025	Northern Trust Corp	250,343	$0.57M	0.0%	+18.9%	0.505%
2/14/2025	Price T Rowe Associates Inc. MD	13,116	$31K	0.0%	N/A	0.026%
2/12/2025	Paragon Associates & Paragon Associates II Joint Venture	801,000	$1.83M	4.2%	+1.4%	1.616%
2/12/2025	JPMorgan Chase & Co.	48,313	$0.11M	0.0%	+295.4%	0.097%
2/11/2025	Intech Investment Management LLC	11,780	$27K	0.0%	N/A	0.024%
2/5/2025	SVB Wealth LLC	515,398	$1.18M	0.0%	N/A	1.040%
2/4/2025	Bank of New York Mellon Corp	50,665	$0.12M	0.0%	-10.1%	0.102%
1/17/2025	SG Americas Securities LLC	12,325	$28K	0.0%	N/A	0.025%
11/19/2024	Barclays PLC	39,472	$0.11M	0.0%	+320.9%	0.080%
11/15/2024	Barclays PLC	39,472	$0.11M	0.0%	+320.9%	0.080%
11/15/2024	Jane Street Group LLC	30,421	$83K	0.0%	-32.0%	0.061%
11/15/2024	State Street Corp	453,296	$1.23M	0.0%	+4.2%	0.916%
11/15/2024	HighTower Advisors LLC	20,200	$55K	0.0%	-25.7%	0.041%
11/12/2024	Charles Schwab Investment Management Inc.	63,002	$0.17M	0.0%	-64.2%	0.127%
11/5/2024	GSA Capital Partners LLP	310,669	$0.85M	0.1%	+87.4%	0.628%
8/16/2024	Regal Investment Advisors LLC	18,760	$44K	0.0%	+64.3%	0.038%
8/14/2024	Squarepoint Ops LLC	65,949	$0.15M	0.0%	-52.3%	0.134%
8/12/2024	XTX Topco Ltd	18,984	$44K	0.0%	-24.4%	0.038%
8/9/2024	Renaissance Technologies LLC	22,200	$52K	0.0%	-56.2%	0.045%
8/1/2024	Rhumbline Advisers	28,732	$67K	0.0%	-15.1%	0.058%
7/26/2024	Bank of New York Mellon Corp	67,468	$0.16M	0.0%	+16.2%	0.137%
7/19/2024	Peddock Capital Advisors LLC	234,926	$0.55M	0.1%	-2.1%	0.476%
5/16/2024	Silvercrest Asset Management Group LLC	580,834	$2.72M	0.0%	N/A	1.176%
5/10/2024	Vanguard Group Inc.	1,454,288	$6.82M	0.0%	+3.3%	2.945%
2/15/2024	Parkman Healthcare Partners LLC	674,787	$3.29M	0.5%	+28.4%	1.375%
2/14/2024	Kent Lake Capital LLC	116,835	$0.57M	0.2%	-84.3%	0.238%
2/13/2024	Tower Research Capital LLC TRC	10,408	$51K	0.0%	+291.0%	0.021%
2/13/2024	CIBC Asset Management Inc	115,644	$0.56M	0.0%	+176.0%	0.236%
2/6/2024	Peddock Capital Advisors LLC	290,720	$1.42M	0.4%	+546.2%	0.592%
1/25/2024	Nisa Investment Advisors LLC	6,059	$30K	0.0%	+10,169.5%	0.012%
11/22/2023	Polar Capital Holdings Plc	1,579,756	$7.35M	0.1%	+4.2%	3.219%
11/15/2023	Kennedy Capital Management LLC	297,764	$1.39M	0.0%	-0.8%	0.607%
11/15/2023	Kent Lake Capital LLC	746,521	$3.47M	1.3%	N/A	1.521%
11/14/2023	Schonfeld Strategic Advisors LLC	129,500	$0.60M	0.0%	+5.9%	0.264%
10/24/2023	Bank of New York Mellon Corp	132,834	$0.62M	0.0%	+8.3%	0.271%
10/23/2023	SVB Wealth LLC	515,317	$2.40M	0.1%	+3.1%	1.053%
10/10/2023	Peddock Capital Advisors LLC	44,992	$0.21M	0.1%	+50.0%	0.092%
9/21/2023	Barclays PLC	3,615	$27K	0.0%	-54.7%	0.007%
8/15/2023	Blue Water Life Science Advisors LP	4,697,785	$34.72M	23.4%	+123.9%	9.599%
8/14/2023	UniSuper Management Pty Ltd	329,756	$2.44M	0.0%	N/A	0.674%
8/14/2023	Polar Capital Holdings Plc	1,515,470	$11.20M	0.1%	+15.2%	3.097%
8/14/2023	Granahan Investment Management LLC	482,196	$3.56M	0.1%	-19.2%	0.985%
8/14/2023	Pura Vida Investments LLC	360,789	$2.67M	0.4%	N/A	0.737%
8/8/2023	Candriam S.C.A.	276,300	$2.04M	0.0%	+7.8%	0.720%
8/7/2023	Peddock Capital Advisors LLC	30,000	$0.22M	0.1%	N/A	0.078%
7/24/2023	Allspring Global Investments Holdings LLC	5,992	$44K	0.0%	-95.0%	0.016%
7/18/2023	Allspring Global Investments Holdings LLC	5,992	$44K	0.0%	-95.0%	0.016%
7/13/2023	ZWJ Investment Counsel Inc.	45,275	$0.34M	0.0%	+4.7%	0.118%
5/25/2023	Legato Capital Management LLC	76,410	$0.63M	0.1%	+56.6%	0.199%
5/16/2023	Altium Capital Management LP	500,000	$4.09M	2.3%	+51.5%	1.302%
5/16/2023	Blue Water Life Science Advisors LP	2,097,785	$17.16M	11.3%	+13.5%	5.463%
5/15/2023	Uniplan Investment Counsel Inc.	465,204	$3.81M	0.3%	+16.2%	1.211%
5/15/2023	RTW Investments LP	328,422	$2.69M	0.1%	-32.1%	0.855%
5/15/2023	Granahan Investment Management LLC	597,119	$4.88M	0.1%	+10.7%	1.555%
5/4/2023	Essex Investment Management Co. LLC	238,703	$1.95M	0.3%	+82.2%	0.622%
4/13/2023	Allspring Global Investments Holdings LLC	118,946	$0.97M	0.0%	-37.0%	0.310%
2/27/2023	Parallax Volatility Advisers L.P.	60,532	$0.58M	0.0%	-83.9%	0.159%
2/14/2023	Granahan Investment Management LLC	539,340	$5.16M	0.2%	+35.2%	1.421%
2/13/2023	Board of Trustees of The Leland Stanford Junior University	620,434	$5.94M	0.6%	-19.9%	1.634%
2/13/2023	Advisory Research Inc.	52,189	$0.50M	0.0%	-38.0%	0.137%
2/10/2023	SVB Wealth LLC	516,957	$4.95M	0.1%	N/A	1.362%
2/10/2023	Lord Abbett & CO. LLC	284,946	$2.73M	0.0%	N/A	0.751%
2/8/2023	Clark Estates Inc. NY	170,541	$1.63M	0.3%	-0.8%	0.449%
2/3/2023	Essex Investment Management Co. LLC	130,988	$1.25M	0.2%	N/A	0.345%
2/1/2023	Legato Capital Management LLC	48,806	$0.47M	0.1%	N/A	0.129%
2/1/2023	DekaBank Deutsche Girozentrale	55,000	$0.52M	0.0%	N/A	0.145%
1/24/2023	ZWJ Investment Counsel Inc.	42,000	$0.40M	0.0%	+3.7%	0.111%
11/16/2022	Advisory Research Inc.	84,113	$0.99M	0.1%	N/A	0.222%
11/15/2022	Clark Estates Inc. NY	171,976	$2.02M	0.4%	-0.7%	0.453%
11/15/2022	Uniplan Investment Counsel Inc.	167,709	$1.97M	0.2%	N/A	0.442%
11/15/2022	Pura Vida Investments LLC	147,500	$1.73M	0.1%	N/A	0.389%
11/15/2022	Parkman Healthcare Partners LLC	161,701	$1.90M	0.5%	-12.5%	0.426%
11/15/2022	Board of Trustees of The Leland Stanford Junior University	774,116	$9.10M	0.6%	-50.8%	2.039%
11/15/2022	Clark Estates Inc. NY	171,976	$2.02M	0.5%	-0.7%	0.453%
11/14/2022	RTW Investments LP	483,815	$5.69M	0.1%	+107.2%	1.275%
11/14/2022	MetLife Investment Management LLC	9,886	$0.12M	0.0%	N/A	0.026%
11/8/2022	New York State Common Retirement Fund	11,739	$0.14M	0.0%	+187.7%	0.031%
11/3/2022	CIBC Asset Management Inc	253,522	$2.98M	0.0%	N/A	0.674%
10/26/2022	Allspring Global Investments Holdings LLC	188,736	$2.22M	0.0%	-18.4%	0.502%
10/19/2022	ZWJ Investment Counsel Inc.	40,500	$0.48M	0.0%	-3.6%	0.108%
8/11/2022	Deutsche Bank AG	270,010	$3.47M	0.0%	+3,228.1%	0.718%
8/8/2022	Clark Estates Inc. NY	173,106	$2.22M	0.4%	N/A	0.461%
8/5/2022	State Board of Administration of Florida Retirement System	10,200	$0.13M	0.0%	N/A	0.027%
8/3/2022	Nisa Investment Advisors LLC	2,000	$26K	0.0%	N/A	0.005%
8/2/2022	ZWJ Investment Counsel Inc.	42,000	$0.54M	0.0%	+110.0%	0.112%
7/25/2022	Allspring Global Investments Holdings LLC	231,220	$2.97M	0.0%	-52.0%	0.615%
5/18/2022	Blue Water Life Science Advisors LP	2,088,668	$22.95M	10.9%	+22.1%	5.556%
5/17/2022	RTW Investments LP	77,676	$0.85M	0.0%	-22.3%	0.207%
5/13/2022	Parkman Healthcare Partners LLC	150,321	$1.65M	0.5%	+20.3%	0.400%
5/10/2022	ZWJ Investment Counsel Inc.	20,000	$0.22M	0.0%	N/A	0.053%
5/9/2022	Qube Research & Technologies Ltd	28,153	$0.31M	0.0%	+44.4%	0.075%
4/26/2022	Exchange Traded Concepts LLC	199,067	$2.19M	0.0%	-4.0%	0.530%
2/10/2022	Candriam Luxembourg S.C.A.	50,300	$0.77M	0.0%	+18.9%	0.135%
2/10/2022	Qube Research & Technologies Ltd	19,501	$0.30M	0.0%	N/A	0.052%
2/8/2022	Northern Trust Corp	108,939	$1.67M	0.0%	+54.0%	0.293%
2/1/2022	Qube Research & Technologies Ltd	19,501	$0.30M	0.0%	N/A	0.052%

Data available starting January 2016

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $1.62

$1.39

$1.62

50 Day Range

MA: $2.30

$1.48

$3.23

52 Week Range

Now: $1.62

$1.39

$5.16

Volume

470,773 shs

Average Volume

346,429 shs

Market Capitalization

$80.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Akoya Biosciences?: Akoya Biosciences' top insider investors include:
Matthew Winkler (Director)
Brian Mckelligon (CEO)
Frederic Pla (COO)
John Frederick Ek (CFO)
Learn More about top insider investors at Akoya Biosciences.
Who are the major institutional investors of Akoya Biosciences?: Akoya Biosciences' top institutional investors include:
Paragon Associates & Paragon Associates II Joint Venture — 1.62%
SVB Wealth LLC — 1.04%
Northern Trust Corp — 0.51%
Schonfeld Strategic Advisors LLC — 0.25%
Deutsche Bank AG — 0.11%
Bank of New York Mellon Corp — 0.10%
Learn More about top institutional investors of Akoya Biosciences stock.
Which major investors are selling Akoya Biosciences stock?: Within the last quarter, AKYA stock was sold by these institutional investors:
Schonfeld Strategic Advisors LLC
Jane Street Group LLC
Bank of New York Mellon Corp
Which major investors are buying Akoya Biosciences stock?: In the last quarter, AKYA stock was bought by institutional investors including:
SVB Wealth LLC
Deutsche Bank AG
Northern Trust Corp
JPMorgan Chase & Co.
Price T Rowe Associates Inc. MD
SG Americas Securities LLC
Intech Investment Management LLC
Paragon Associates & Paragon Associates II Joint Venture
During the last year, these company insiders have bought Akoya Biosciences stock:
Matthew Winkler (Director)
Brian Mckelligon (CEO)
Frederic Pla (COO)
Learn More investors buying Akoya Biosciences stock.